Shenzhen Lifotronic Technology Co Total Liabilities
Shenzhen Lifotronic Technology Co total liabilities. Based on the latest financial reports, Shenzhen Lifotronic Technology Co (688389) has total liabilities worth CN¥382.72 Million CNY (≈ $56.00 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shenzhen Lifotronic Technology Co asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shenzhen Lifotronic Technology Co (2016–2025)
Total liabilities of Shenzhen Lifotronic Technology Co from 2016 to 2025. This chart illustrates how Shenzhen Lifotronic Technology Co's total liabilities have evolved over time, based on quarterly financial data.
Shenzhen Lifotronic Technology Co Competitors by Total Liabilities
The table below lists competitors of Shenzhen Lifotronic Technology Co ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SGSG Science&technology Co Ltd Zhuhai
SHE:300561
|
China | CN¥67.31 Million |
|
BW Offshore Ltd
OL:BWO
|
Norway | Nkr2.98 Billion |
|
Arrowhead Properties Ltd B
JSE:FTB
|
South Africa | ZAC4.72 Billion |
|
ADITYA VISION LTD
NSE:AVL
|
India | Rs7.83 Billion |
|
Anhui Coreach Technology Co Ltd
SHE:002983
|
China | CN¥563.08 Million |
|
Nanjing Kangni Mechanical & Electrical Co Ltd
SHG:603111
|
China | CN¥3.20 Billion |
|
TPK Holding Co Ltd
TW:3673
|
Taiwan | NT$50.68 Billion |
|
Sapphire Foods India Limited
NSE:SAPPHIRE
|
India | Rs18.67 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Shenzhen Lifotronic Technology Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shenzhen Lifotronic Technology Co assets under control.
Liquidity & Leverage Metrics
Shenzhen Lifotronic Technology Co Total Liabilities Ratios Explained
Shenzhen Lifotronic Technology Co total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shenzhen Lifotronic Technology Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shenzhen Lifotronic Technology Co (2016–2025)
The table below shows the annual total liabilities of Shenzhen Lifotronic Technology Co from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥700.79 Million ≈ $102.55 Million |
-17.08% |
| 2024-12-31 | CN¥845.13 Million ≈ $123.67 Million |
+58.34% |
| 2023-12-31 | CN¥533.76 Million ≈ $78.11 Million |
+41.57% |
| 2022-12-31 | CN¥377.02 Million ≈ $55.17 Million |
+74.14% |
| 2021-12-31 | CN¥216.50 Million ≈ $31.68 Million |
+48.31% |
| 2020-12-31 | CN¥145.98 Million ≈ $21.36 Million |
+12.91% |
| 2019-12-31 | CN¥129.29 Million ≈ $18.92 Million |
-9.92% |
| 2018-12-31 | CN¥143.53 Million ≈ $21.00 Million |
+16.56% |
| 2017-12-31 | CN¥123.15 Million ≈ $18.02 Million |
-2.80% |
| 2016-12-31 | CN¥126.69 Million ≈ $18.54 Million |
-- |
About Shenzhen Lifotronic Technology Co
Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blo… Read more